While the numbers have also been boosted by a jump in government testing, the fact that one in three tests are positive for the pathogen signals strong community transmission in the country.
South Africa’s 25 November announcement that, together with Botswana, it had identified the new variant has sparked concern that the strain could rapidly spread around the globe.
The positivity rate — the proportion of tests that are positive — was 35%, according to the ministry. That compares with 1.4% two weeks ago.
Still, little sequencing of samples has been done to determine which variant they are.
“We are at the stage of mass infections and rising hospitalizations, which is an ominous sign,” Solwayo Ngwenya, the acting chief executive officer at Mpilo Hospital, said from the nation’s second-biggest city of Bulawayo.
Hospital groups in South Africa have so far reported that the strain appears to cause milder illness than earlier variants.
Zimbabwe conducted 11 535 tests on Tuesday compared with 2 500 the day earlier, Mahomva said.
Disruptions to business because of the surge in infections are increasing, with the University of Zimbabwe announcing a suspension of in-person classes from 9 December, a week earlier than planned for its end-of-year break. The Judicial Services Commission, which has oversight of the country’s judiciary, said on Wednesday operations at the High Court and several magistrate’s courts will be suspended.
Zimbabwe is targeting vaccinating 60% of its 15 million population. Less than 3 million people, or about 20% of the population, have so far been fully vaccinated.